Healthcare
Live Price
Offline$0.707
-0.70% today
1Y Change
-74.97%
Window
Jun 23, 2025 → Jun 16, 2026
Coverage: 247 bars · Jun 23, 2025 → Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Skye Bioscience, Inc. (SKYE) is a Healthcare stock with a market cap of $30.00M and listed on NASDAQ. The stock last traded around $0.71 and down 75.0% across the available one-year price window (Jun 23, 2025 → Jun 16, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of -93.2%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS -93.2%, free cash flow -60.5% with operating margin 0.0% and ROIC -286.6%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SKYE price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SKYE
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SKYE Max Drawdown
-87.85%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SKYE and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.